Nanoviricides Inc (NNVC)
2.07
-0.16
(-7.17%)
USD |
NYAM |
May 17, 16:00
2.08
+0.01
(+0.48%)
After-Hours: 20:00
Nanoviricides Accounts Payable (Quarterly): 0.2667M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.2667M |
September 30, 2023 | 0.2292M |
June 30, 2023 | 0.1571M |
March 31, 2023 | 0.0627M |
December 31, 2022 | 0.0393M |
September 30, 2022 | 0.0377M |
June 30, 2022 | 0.058M |
March 31, 2022 | 0.123M |
December 31, 2021 | 0.1532M |
September 30, 2021 | 0.1162M |
June 30, 2021 | 0.20M |
March 31, 2021 | 0.0982M |
December 31, 2020 | 0.1851M |
September 30, 2020 | 0.2582M |
June 30, 2020 | 0.3807M |
March 31, 2020 | 0.4102M |
December 31, 2019 | 0.6724M |
September 30, 2019 | 0.6568M |
June 30, 2019 | 0.3099M |
March 31, 2019 | 0.2467M |
December 31, 2018 | 0.2238M |
September 30, 2018 | 0.3201M |
June 30, 2018 | 0.2233M |
March 31, 2018 | 0.1955M |
December 31, 2017 | 0.0758M |
Date | Value |
---|---|
September 30, 2017 | 0.0904M |
June 30, 2017 | 0.1358M |
March 31, 2017 | 0.1127M |
December 31, 2016 | 0.1261M |
September 30, 2016 | 0.2694M |
June 30, 2016 | 0.0965M |
March 31, 2016 | 0.0719M |
December 31, 2015 | 0.1762M |
September 30, 2015 | 0.0585M |
June 30, 2015 | 0.0895M |
March 31, 2015 | 0.0234M |
December 31, 2014 | 0.502M |
September 30, 2014 | 0.156M |
June 30, 2014 | 0.3764M |
March 31, 2014 | 0.255M |
December 31, 2013 | 0.2443M |
September 30, 2013 | 0.4081M |
June 30, 2013 | 0.2633M |
March 31, 2013 | 0.2377M |
December 31, 2012 | 0.9532M |
September 30, 2012 | 0.8255M |
June 30, 2012 | 0.2384M |
March 31, 2012 | 0.5939M |
December 31, 2011 | 0.9652M |
September 30, 2011 | 0.8082M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.0377M
Minimum
Sep 2022
0.6724M
Maximum
Dec 2019
0.2323M
Average
0.1851M
Median
Dec 2020
Accounts Payable (Quarterly) Benchmarks
EyePoint Pharmaceuticals Inc | 7.082M |
Enanta Pharmaceuticals Inc | 6.726M |
GlycoMimetics Inc | 0.7555M |
FibroGen Inc | 4.353M |
Corvus Pharmaceuticals Inc | 1.609M |